医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer

广告
第一作者: Ratner,E.S.
作者单位: Department of Population Sciences, Beckman Research Institute of the City of Hope, Duarte, CA [1] Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT, United [2] Division of Clinical Cancer Genetics, City of Hope, Duarte, CA, United States [3] Department of Therapeutic Radiology, Yale University, 333 Cedar St, New Haven, CT 06520, United [4] Department of Epidemiology and Public Health, Yale University, New Haven, CT, United States [5] Department of Gynecological Oncology, University of Turin, Turin, Italy [6] Department of Gynecological Oncology, Yale University, New Haven, CT, United States [7] Renal Division, Department of Medicine and Center for Molecular Medicine Cologne, University of [8] Division of Gynecologic Oncology, Angelo Nocivelli Institute of Molecular Medicine, University of [9] Institute for Pharmacy and Molecular Biotechnology, University of Heidelberg, Heidelberg, Germany [10] Department of Medical Oncology, City of Hope, Duarte, CA, United States [11] Yale University School of Medicine, New Haven, CT, United States [12]
发布时间 2013-11-20
提交
  • 浏览0
Oncogene

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷